|
YARS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.700440E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.784400E-01 |
| Normal-vs-Stage2 |
5.854600E-01 |
| Normal-vs-Stage3 |
3.369000E-01 |
| Normal-vs-Stage4 |
2.784400E-03 |
| Stage1-vs-Stage2 |
4.712200E-01 |
| Stage1-vs-Stage3 |
2.427600E-01 |
| Stage1-vs-Stage4 |
1.602670E-03 |
| Stage2-vs-Stage3 |
7.973400E-01 |
| Stage2-vs-Stage4 |
1.865970E-02 |
| Stage3-vs-Stage4 |
2.443700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.476400E-01 |
| Normal-vs-AfricanAmerican |
5.199000E-01 |
| Normal-vs-Asian |
2.568600E-01 |
| Caucasian-vs-AfricanAmerican |
9.682600E-01 |
| Caucasian-vs-Asian |
3.192000E-01 |
| AfricanAmerican-vs-Asian |
1.605580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.251200E-01 |
| Normal-vs-Female |
2.663900E-02 |
| Male-vs-Female |
7.854400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.968600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.313600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.511040E-01 |
| Normal-vs-Age(81-100Yrs) |
7.996400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.351400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.270200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.632600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.198200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.074200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.768800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.348400E-01 |
| Normal-vs-Grade 2 |
8.122000E-01 |
| Normal-vs-Grade 3 |
2.643600E-01 |
| Normal-vs-Grade 4 |
8.661900E-03 |
| Grade 1-vs-Grade 2 |
9.774800E-01 |
| Grade 1-vs-Grade 3 |
6.376400E-01 |
| Grade 1-vs-Grade 4 |
4.413700E-02 |
| Grade 2-vs-Grade 3 |
1.336230E-01 |
| Grade 2-vs-Grade 4 |
5.523500E-03 |
| Grade 3-vs-Grade 4 |
3.203900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.626100E-02 |
| Normal-vs-ccB subtype |
5.443500E-03 |
| ccA subtype-vs-ccB subtype |
1.52287999999334E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.080000E-02 |
| Normal-vs-N1 |
1.593980E-02 |
| N0-vs-N1 |
3.640200E-02 |
|
|
